Cargando…
CCNE1 and E2F1 Partially Suppress G1 Phase Arrest Caused by Spliceostatin A Treatment
The potent splicing inhibitor spliceostatin A (SSA) inhibits cell cycle progression at the G1 and G2/M phases. We previously reported that upregulation of the p27 cyclin-dependent kinase inhibitor encoded by CDKN1B and its C-terminal truncated form, namely p27*, which is translated from CDKN1B pre-m...
Autores principales: | Kikuchi, Kei, Kaida, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584075/ https://www.ncbi.nlm.nih.gov/pubmed/34769053 http://dx.doi.org/10.3390/ijms222111623 |
Ejemplares similares
-
Syntheses of spliceostatins and thailanstatins: a review
por: Donaldson, William A
Publicado: (2020) -
Enantioselective Synthesis of Spliceostatin E and
Evaluation of Biological Activity
por: Ghosh, Arun K., et al.
Publicado: (2014) -
Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A
por: Yoshimoto, Rei, et al.
Publicado: (2017) -
CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1
por: Yu, Tianfu, et al.
Publicado: (2017) -
Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation
por: Roybal, Gabriel A., et al.
Publicado: (2010)